Company
Every investor coverage indicates participated in a round Queensland Emory Drug Discovery Initiative raised.
Companies Queensland Emory Drug Discovery Initiative acquired or merged with, per published coverage. Buying a company is not investing in one: nothing here counts in the deals column.
Stories naming Queensland Emory Drug Discovery Initiative. Where several outlets covered the same round, they are bundled under whichever ran the fullest account.
UniQuest and Molecule to Medicine have formed Curlew Bio to develop anti-inflammatory drugs, backed by $1 million from UniQuest's Extension Fund; the article also recalls Novartis's 2015 purchase of Spinifex Pharmaceuticals.
CUREator, Brandon BioCatalyst's government-backed grant program, has awarded $7.21 million across eight Australian biotech firms in its newest round, split between clinical-stage and preclinical recipients.
Also Brandon BioCatalyst portfolio·Startup Daily·ausceleratesa.org